Cigna Group $CI Shares Sold by PKO Investment Management Joint Stock Co

PKO Investment Management Joint Stock Co lessened its stake in shares of Cigna Group (NYSE:CI) by 19.5% during the 1st quarter, Holdings Channel reports. The firm owned 9,100 shares of the health services provider’s stock after selling 2,200 shares during the quarter. PKO Investment Management Joint Stock Co’s holdings in Cigna Group were worth $2,427,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the stock. Banco Bilbao Vizcaya Argentaria S.A. raised its stake in shares of Cigna Group by 13.5% in the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after purchasing an additional 4,066 shares during the last quarter. Distillate Capital Partners LLC boosted its position in Cigna Group by 19.1% in the third quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock valued at $31,338,000 after buying an additional 17,442 shares during the last quarter. Cooperman Leon G boosted its position in Cigna Group by 53.3% in the third quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock valued at $93,681,000 after buying an additional 113,000 shares during the last quarter. Schroder Investment Management Group increased its holdings in Cigna Group by 53.0% in the 3rd quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider’s stock worth $54,972,000 after buying an additional 66,090 shares during the period. Finally, apricus wealth LLC raised its position in Cigna Group by 715.9% during the 4th quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after buying an additional 8,340 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages have commented on CI. Cantor Fitzgerald lifted their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Mizuho raised their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Royal Bank Of Canada boosted their target price on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. Guggenheim upped their price target on shares of Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, UBS Group lifted their price objective on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $338.30.

Cigna Group Stock Performance

CI opened at $282.08 on Tuesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a fifty day moving average price of $283.86 and a 200 day moving average price of $278.42. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The stock has a market cap of $74.62 billion, a P/E ratio of 11.96, a P/E/G ratio of 1.08 and a beta of 0.28.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same quarter last year, the business earned $6.74 earnings per share. The firm’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.